Response Genetics Reaches Contract with PPO Three Rivers Provider Network | GenomeWeb

NEW YORK (GenomeWeb News) – Response Genetics today announced it has reached a contract with preferred provider organization Three Rivers Provider Network.

As a result, the more than 10 million members in Three Rivers will have access to Response's predictive genomic tests, which provides insight into a patient's tumor and potentially effective therapies.

Financial and other terms of the deal were not disclosed.

Three Rivers comprises more than 600,000 total providers, including more than 5,000 hospitals and 70,000 ancillary facilities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.